Axogen Corporation

Paul G. Thomas

Paul Thomas has served as a member of our Board of Directors since September 2020 and became Chairman of the Board in August 2024. Mr. Thomas has more than 30 years of experience in the medtech industry and currently serves as the Chief Executive Officer and Co-Founder of Prominex, Inc. From 2009…

Amy Wendell

Amy Wendell has served as a member of our Board of Directors since September 2016 and Lead Independent Director from May 2018 through August 2024. From January 2016 through April 2019, Ms. Wendell was a senior advisor for the healthcare investment banking practice of Perella Weinberg Partners…

Ivica Ducic, M.D., PhD

Dr. Ducic joined Axogen as Medical Director in January 2017. A board-certified plastic surgeon with additional training and expertise in nerve surgery, Dr. Ducic received an M.D. degree from the University of Zagreb (Croatia, EU), and a Ph.D. in neuroscience in 1995. Upon completion of his plastic…

Craig Swandal

Mr. Swandal joined Axogen in January 2025 as the Vice President of Operations. With over 25 years of operational leadership experience in medical device, he brings a wealth of expertise in leading high-growth, global manufacturing companies. His career spans a broad spectrum of organizations, from…

Doris Quackenbush

Doris Quackenbush serves as Chief Revenue Officer at Axogen, with global responsibility for leading sales operations and commercial execution worldwide.   Prior to her appointment as Chief Revenue Officer, Ms. Quackenbush served as Axogen’s Vice President of Sales beginning in January 2022.…

Marc Began

Mr. Began assumed the role of Executive Vice President and General Counsel in March of 2023. He brings more than 25 years of experience representing life science companies as in-house and external counsel. From June 2018 until its acquisition in December 2022 by Johnson and Johnson, Inc., he served…